Early surveillance is associated with less incidence and severity of breast cancer–related lymphedema compared with a traditional referral model of care
Open Access
- 6 December 2018
- Vol. 125 (6), 854-862
- https://doi.org/10.1002/cncr.31873
Abstract
Background Bioimpedance spectroscopy (BIS) has enabled the early identification of breast cancer‐related lymphedema. In this study, differences in health service metrics and in the incidence of breast cancer‐related lymphedema are evaluated in an early surveillance model of care compared with a traditional referral model of care. Methods In a retrospective analysis of data from 753 women who underwent BIS measures between January 1, 2007 and December 31, 2016, 188 women were assigned to the “early surveillance” group if they began lymphedema monitoring presurgery (n = 121) or within 90 days postsurgery (n = 67), and 285 women were assigned to the “traditional referral” group if they began monitoring after 90 days postsurgery. Health service metrics were calculated as the time to the first BIS measure after 90 days postsurgery, the median follow‐up, and the number of health care visits. Lymphedema was diagnosed based on BIS measures. Results Women in the early surveillance group received lymphedema care significantly earlier than those in the traditional referral group. However, there was no difference in the number of visits per year to the clinic between groups. Significantly more women in the traditional referral group were diagnosed with clinical lymphedema (stage I‐III, 39 % vs 14%; P < .001) and with greater severity (stage II‐III, 24%) compared with those in the early surveillance group (4%). Conclusions The current findings support the adoption of an early prospective surveillance model of care using BIS for the early detection and management of breast cancer‐related lymphedema.Keywords
Funding Information
- ImpediMed Limited
- Australian Lymphoedema Education, Research, and Treatment (ALERT) Program, Macquarie University
This publication has 37 references indexed in Scilit:
- Breast Cancer–Related Lymphedema: Comparing Direct Costs of a Prospective Surveillance Model and a Traditional Model of CarePTJ: Physical Therapy & Rehabilitation Journal, 2012
- STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME): An Extension of the STROBE StatementPLoS Medicine, 2011
- Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up StudyJournal of Clinical Oncology, 2009
- Lymphedema After Breast Cancer: Incidence, Risk Factors, and Effect on Upper Body FunctionJournal of Clinical Oncology, 2008
- Preoperative assessment enables the early diagnosis and successful treatment of lymphedemaCancer, 2008
- Bioelectrical Impedance Analysis: Proven Utility in Lymphedema Risk Assessment and Therapeutic MonitoringLymphatic Research and Biology, 2006
- Bioimpedance Analysis: Scientific BackgroundLymphatic Research and Biology, 2006
- Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancerBritish Journal of Surgery, 2003
- Bioelectrical impedance for monitoring the efficacy of lymphoedema treatment programmesBreast Cancer Research and Treatment, 1996
- MuIti‐frequency bioelectrical impedance augments the diagnosis and management of lymphoedema in post‐mastectomy patientsEuropean Journal of Clinical Investigation, 1992